How Merck Is Trying to Keep Disrupters at Bay
Harvard Business Review
JUNE 8, 2015
But “reports of my death are greatly exaggerated,” as Mark Twain said. With its Emerging Businesses (EB) group (where one of us serves as President), Merck started a journey about three years ago with a core investment thesis: there are areas of growing unmet need in health care that intersect with its established competencies.
Let's personalize your content